Back

Thorax

29 training papers 2019-06-25 – 2026-03-07

Top medRxiv preprints most likely to be published in this journal, ranked by match strength.

1
E-cigarette Duration and Incident COPD Among Adults Aged 40 Years and Older with a Smoking History
2026-02-05 respiratory medicine 10.64898/2026.02.04.26345592
#1 (11.7%)
Show abstract

ImportanceChronic obstructive pulmonary disease (COPD) remains a leading cause of morbidity and mortality in the United States (US), largely driven by cigarette smoking and characterized by progressive lung injury. While e-cigarettes are promoted as a less harmful alternative to cigarette smoking, their long-term health effects, including the impact of prolonged use on COPD incidence among adults who have smoked, are not well understood. ObjectiveTo evaluate the prospective association between ...

2
The Road to Recovery: Dose-Response Effects of CPAP on Real-World Driving Performance in Obstructive Sleep Apnoea
2026-01-22 respiratory medicine 10.64898/2026.01.20.26344436
#1 (11.3%)
Show abstract

BackgroundObstructive Sleep Apnoea (OSA) increases motor vehicle collision risk, and while Continuous Positive Airway Pressure (CPAP) considerably reduces this risk, it remains unclear how much CPAP use is required to fully normalise driving behaviour, and whether baseline (Pre-CPAP) driving style influences treatment response. MethodsIn a prospective observational study embedded within routine clinical care, real-world driving behaviour was recorded using a smartphone telematics application in...

3
Impact of Educational Resources for Primary Care OSA Management on Referral Patterns
2026-01-22 respiratory medicine 10.64898/2026.01.21.26344482
#1 (10.2%)
Show abstract

Background/ObjectiveBarriers in access to care have prompted development of innovative care delivery models for patients with obstructive sleep apnea (OSA). One such innovation is management of uncomplicated OSA by primary care providers (PCPs), which reserves specialist capacity for more complex patients. We developed a clinical guideline and subsequently, an online clinical pathway to support PCPs in OSA management. We aimed to evaluate the impact of these initiatives on PCP behaviour by asses...

4
Restriction with Normal Spirometry: A Retrospective Cohort Study
2025-12-16 respiratory medicine 10.64898/2025.12.15.25342141
Top 0.1% (9.9%)
Show abstract

BackgroundThough a normal forced vital capacity (FVC) is typically thought to imply the absence of restriction, recent data suggest that restriction may in fact be common among patients with normal spirometry. However, the clinical significance of restriction with normal spirometry is unknown. Research QuestionWhat clinical characteristics and outcomes are associated with restriction with normal spirometry? Study Design and MethodsWe interpreted pulmonary function tests (PFTs) with both static...

5
Adult Life Course Trajectories of Lung Function and the Development of Interstitial Lung Abnormalities: The CARDIA Lung Study
2026-03-06 respiratory medicine 10.64898/2026.03.03.26347486
Top 0.1% (9.6%)
Show abstract

Background: Interstitial lung abnormalities (ILA) are radiologic findings of increased lung density or fibrosis in individuals without clinical interstitial lung disease (ILD) and are associated with increased mortality and progression to ILD. Understanding physiologic trajectories of lung function preceding ILA diagnosis may illuminate early mechanisms of lung injury. Methods: We recruited participants from the Coronary Artery Risk Development in Young Adults (CARDIA) Lung Study, a prospective ...

6
Upper airway ciliary dysfunction in bronchiectasis: The EMBARC cilia cohort study
2026-02-04 respiratory medicine 10.64898/2026.02.03.26345362
Top 0.3% (8.1%)
Show abstract

Mucociliary clearance is a key component of the pathophysiology of bronchiectasis but cilia function is poorly defined. This study aims to characterize nasal ciliary function in bronchiectasis and examine associations with disease severity, infection, inflammation and outcome. Adults with bronchiectasis and healthy volunteers were recruited to the international observational study EMBARC-BRIDGE. Individuals with a known diagnosis of Primary Ciliary Dyskinesia (PCD) were excluded. Nasal respira...

7
Differential association of body mass index with hypoglossal nerve stimulation efficacy by pharyngeal collapse pattern in obstructive sleep apnea
2026-01-26 respiratory medicine 10.64898/2026.01.25.26344734
Top 0.3% (7.9%)
Show abstract

IntroductionUnilateral hypoglossal nerve stimulation (HGNS) is an approved surgical therapy for obstructive sleep apnea (OSA), but its efficacy is limited by obesity and unfavorable (laterally directed) pharyngeal collapse patterns. This study tested whether the effect of body mass index (BMI) on HGNS efficacy differs by pharyngeal collapse pattern, specifically comparing laterally directed and anteroposterior (AP) collapse. MethodsWe pooled data from two independent HGNS cohorts (n=760) to eva...

8
Respiratory and Gut Microbiota Correlate with Lung Function Recovery after Severe COVID-19
2026-02-10 respiratory medicine 10.64898/2026.02.09.26345630
Top 0.4% (7.9%)
Show abstract

RationaleSevere SARS-CoV-2 infection induces disrupted oropharyngeal and gut microbiota during acute disease which may persist and contribute to the development of post-acute pulmonary sequelae. To date, it is unclear whether dysbiosis following severe disease is linked to long-term pulmonary function impairment. ObjectivesTo determine associations between oropharyngeal and gut microbiota composition with lung function after severe COVID-19. Methods16S and internal transcribed spacer (ITS) rRN...

9
Therapeutic Response by Radiologic Pattern of Lung Injury in Myositis-Associated Interstitial Lung Disease: a Retrospective Cohort Study
2026-03-04 respiratory medicine 10.64898/2026.03.03.26347563
Top 0.4% (7.3%)
Show abstract

ObjectiveMyositis-associated interstitial lung disease (myositis-ILD) consists of two predominant radiologic patterns of lung injury--nonspecific interstitial pneumonia (NSIP) and organizing pneumonia (OP)--that oftentimes coexist. However, it remains unclear whether either is associated with clinical outcomes. We aimed to assess the therapeutic response in patients with NSIP-compared to those with OP-predominant myositis-ILD. MethodsThis retrospective, single-center cohort study recruited part...

10
Baseline predictors of mortality in non-idiopathic pulmonary fibrosis interstitial lung disease - A retrospective cohort study at a tertiary centre in Malaysia
2026-02-15 respiratory medicine 10.64898/2026.02.12.26346139
Top 0.4% (7.0%)
Show abstract

Background and AimsThe prognosis of interstitial lung diseases (ILDs) other than idiopathic pulmonary fibrosis (IPF) has not been studied as extensively as IPF. This study aimed to evaluate baseline factors associated with mortality in non-IPF ILD, including demographic characteristics, respiratory function test (RFT), comorbidities, and ILD subtypes. MethodsThis retrospective cohort study analysed prospectively collected data of patients with non-IPF ILD at a single tertiary centre in Malaysia...

11
Age-dependent Genetic Risk in Pulmonary Fibrosis Patients and Relatives
2026-01-15 respiratory medicine 10.64898/2026.01.07.25342496
Top 0.4% (7.0%)
Show abstract

AbstractO_ST_ABSRationaleC_ST_ABSIdiopathic pulmonary fibrosis (IPF) is an age-related disorder with common and rare genetic risk factors. It is unknown if the effects of PF genetic risk factors differ by chronologic age. ObjectivesTo assess age-specific effects of genetic risk factors in PF patients and their relatives. MethodsWe identified common and rare genetic risk factors using a Columbia whole genome sequencing (WGS) cohort (777 IPF, 2905 controls) and replicated findings using Trans-Om...

12
Burden of Bronchiectasis Among COPD Patients in Bangladesh: Insights from a Cross-Sectional Study
2025-12-18 respiratory medicine 10.64898/2025.12.16.25342432
Top 0.4% (6.9%)
Show abstract

BackgroundBronchiectasis is an increasingly recognized structural complication among patients with chronic obstructive pulmonary disease (COPD), yet evidence from Bangladesh remains limited. This study aimed to determine the prevalence, clinical characteristics, radiological patterns, and associated factors of bronchiectasis among COPD patients in tertiary-level hospitals. MethodsA cross-sectional study was conducted among 129 COPD patients regardless of age distribution, all are met GOLD crite...

13
Serum Tumor Marker Profiles in Interstitial Lung Diseases: Implications for Differential Diagnosis and Disease Severity Assessment
2026-01-16 respiratory medicine 10.64898/2026.01.13.26344081
Top 0.5% (6.9%)
Show abstract

BackgroundInterstitial lung diseases (ILDs), including idiopathic pulmonary fibrosis (IPF) and connective tissue disease-associated ILD (CTD-ILD), share similar features that complicate diagnosis. Tumor markers are often elevated in ILD, yet their diagnostic utility remains unclear. MethodsThis retrospective study included ILD patients hospitalized between 2018 and 2025. Serum levels of alpha-fetoprotein, carcinoembryonic antigen (CEA), carbohydrate antigen (CA) 199, CA125, CA153, neuron-specif...

14
Portable Breathing Monitoring with Phase-Resolved Airflow Dynamics Enabled by a Dual-Response Flexible PZT Sensor
2026-02-14 respiratory medicine 10.64898/2026.02.09.26345795
Top 0.5% (6.7%)
Show abstract

Respiratory monitoring in daily-life settings is important for health assessment, yet extracting physiologically interpretable information from breathing signals under natural conditions remains challenging, as breathing is inherently dynamic and strongly modulated by behavior. Here, a portable breathing monitoring device based on a flexible lead zirconate titanate sensor is developed to address this challenge. By exploiting polarity-opposed piezoelectric and pyroelectric responses through senso...

15
Development and validation of a parent proxy bronchiectasis child quality of life instrument: The BC-QoL
2025-12-17 respiratory medicine 10.64898/2025.12.15.25341944
Top 0.6% (6.7%)
Show abstract

BackgroundQuality of life (QoL), the highest prioritised outcome by children with bronchiectasis and their parents, is a patient-reported outcome measure increasingly considered essential when evaluating health and interventions. Despite this, there are no validated instruments that specifically measure QoL related to bronchiectasis in children. We aimed to develop and validate a new bronchiectasis child-specific parent-proxy QoL instrument (BC-QoL). MethodsWe developed a draft 44-item BC-QoL a...

16
Integrative multi-omic analyses identify major axes of heterogeneity in chronic obstructive pulmonary disease and uncover their molecular contributors
2026-01-24 respiratory medicine 10.64898/2026.01.22.26344654
Top 0.6% (6.6%)
Show abstract

Chronic obstructive pulmonary disease (COPD) is a debilitating and progressive lung disease that affects millions of people worldwide. There is a continuing clinical need to characterize COPD at the molecular level to be able to identify the multi-omic biomarkers of its pathogenesis and to enable more accurate diagnoses and more effective treatment. We used Multi-Omics Factor Analysis (MOFA) to jointly analyze genomic, blood transcriptomic, and plasma proteomic data collected from 1,872 particip...

17
Investigating the Effect of Climate and Air Pollution on Prescription Uptake in the England
2026-02-16 health policy 10.64898/2026.02.13.26346258
Top 0.6% (6.6%)
Show abstract

BackgroundClimate change is increasingly recognised as a threat to population health and healthcare systems, yet the effects of environmental variability on pharmaceutical prescribing remain poorly characterised in the UK. Using a wide array of open-source datasets, we examine the effect of environmental, geographic and socioeconomic factors on prescribing habits in England. MethodsWe linked monthly, practice-level prescribing data for England (2010-2025) to meteorological, air-quality, floodin...

18
Functional Capacity and Physical Activity in COPD: Associations with Hospitalizations, Health related Quality of Life and Mortality. A Prospective study
2026-01-06 respiratory medicine 10.64898/2026.01.04.26343342
Top 0.6% (6.5%)
Show abstract

ObjectiveTo demonstrate the association between hospital admissions, health-related quality of life (HRQoL), limitations in daily activities, mortality, and survival in relation to physical activity (PA) and functional capacity (FC), which were used together to classify a cohort of COPD patients. MethodsProspective study. Participants were consecutively recruited from six outpatient respiratory clinics of a single university hospital. Data were recorded on sociodemographic and clinical variable...

19
Microbial Ecological Signatures Predict Pathogen Emergence and Multidrug Resistance in Cystic Fibrosis Airways up to a Year in Advance
2026-01-02 respiratory medicine 10.64898/2025.12.28.25342520
Top 0.6% (6.5%)
Show abstract

Chronic infections in cystic fibrosis (CF) emerge from gradual ecological transitions in the airway microbiome, yet early predictive markers remain poorly defined. We developed a new autoencoder-based framework that outperforms read-based or metagenome-assembled genome-based analyses at capturing the continuum from health-associated commensals to pathogen-dominated, antibiotic-tolerant communities. This improvement is achieved by integrating taxonomic and functional data from 127 sputum and bron...

20
Efficacy and Safety of Sitafloxacin-Containing Regimen for Improved Treatment of Nontuberculous Mycobacterial Lung Disease: A Multi-Center Retrospective Study
2026-01-16 respiratory medicine 10.64898/2026.01.13.26343918
Top 0.7% (6.4%)
Show abstract

ObjectivesTo evaluate the efficacy and safety of sitafloxacin-containing regimens versus non-sitafloxacin therapy in patients with nontuberculous mycobacterial (NTM) pulmonary disease, focusing on sputum/BALF conversion rate, time of sputum/BALF culture conversion and radiographic improvement. MethodsThis retrospective cohort study analyzed 149 adults (76 control group vs. 73 sitafloxacin group) with NTM pulmonary disease treated between 2021 to 2024. Inclusion criteria: (1) Sitafloxacin group:...